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Stanworth and colleagues have explored the relation 
between blood loss and mortality in trauma patients in a 
study stimulated by the changing approach to early 
trauma management [1]. Th   e traditional approach advo-
cates packed red blood cell (PRBC) transfusions and early 
coagulation testing in the hospital laboratory using assays 
such as the prothrombin time ratio, the activated partial 
thromboplastin time ratio, and platelet concentration. 
Transfusion of fresh frozen plasma, platelets, and 
sometimes cryoprecipitate was based on results that may 
be delayed for 60 minutes following sampling. Current 
guidelines recommend transfusion when prothrombin 
time ratio or activated partial thromboplastin time ratio 
>1.5, platelet count <50 × 109/l, or ﬁ  brinogen level <1.5 to 
2.0 g/l [2], or after a certain proportion of the circulating 
volume is lost. Th   is approach is inherently reactive rather 
than proactive and is at risk of closing the door after the 
horse has bolted. Our increasing understanding that shock 
and hypoperfusion can initiate inﬂ  ammation,  which  is 
closely linked to coagulation, creates biological plausi-
bility that the traditional approach may not be best for 
injured patients.
Up to one-quarter of trauma patients have deranged 
coagulation on arrival in the emergency department [3], 
which is more severe with greater injury severity [3], 
acidosis and shock [4], and is associated with higher 
PRBC use and mortality [5]. Th  is has led to the new 
concept of haemostatic resuscitation, which advocates 
point-of-care coagulation testing, higher ratios of fresh 
frozen plasma and platelets to PRBC, fresh whole blood 
where available, minimal crystalloid, and early considera-
tion of cryoprecipitate, ﬁ  brinogen, activated recombinant 
factor VII and tranexamic acid [5-10]. Evidence from 
cohort studies suggests these interventions are associated 
with increased survival [7-10]. War in Iraq and 
Afghanistan has accelerated this area of research, and 
further high-quality evidence for military and civilian 
settings is highly desirable.
Because haemostatic resuscitation aims to hit the 
problem hard and early, the technique raises several 
challenges – especially the logistics of providing blood 
products quickly and safely. Perhaps most challenging is 
quickly recog  nising patients in whom early haemostatic 
resuscitation is indicated. Trauma patients have a wide 
range of injury severity, meaning ﬂ  uid  requirements 
range from nothing to massive transfusion. Unnecessary 
transfusion will drain systems of blood products in 
limited supply, and will increase the risk of transfusion 
complications.
Stanworth and colleagues have addressed this issue by 
analysing pooled data from trauma registries in ﬁ  ve 
countries in Europe and North America [1]. Th  ey  asked 
two questions: ﬁ  rst, is there a threshold eﬀ  ect in PRBC 
use on hospital mortality? Second, can clinical and 
laboratory parameters available soon after arrival in the 
emergency department predict who will go on to require 
massive PRBC transfusion? If a threshold value was 
found, this might be a useful way of triaging patients, 
whereas predictive early parameters might be used as a 
diagnostic test to trigger major haemorrhage protocols 
and the use of haemostatic resuscitation.
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authors found a clear relationship between the number of 
PRBCs transfused in the ﬁ  rst 24 hours and death rates, 
but no threshold eﬀ  ect.  Th  is observation suggests we 
should not use arbitrary thresholds of blood loss or blood 
product use in conceptualising the risk of death, but 
should acknowledge that all increments represent pro-
gres  sive increased risk. Th  e external validity of the 
ﬁ  ndings needs to acknowledge the fact that the centres 
involved were well established with high levels of 
expertise in trauma management, and the relationship 
might be diﬀ  erent in other healthcare organisations. Th  e 
many factors that inﬂ  uence trauma outcomes also mean 
that eﬀ  ect modi  ﬁ  ers could alter the relationship between 
PRBC trans  fusion and mortality. Th  e authors provide 
compelling evi  dence that with modern trauma care there 
is no obvious ceiling eﬀ  ect, however, and they emphasise 
the biological plausibility of using ongoing PRBC require-
ment as an index of mortality risk.
Despite the lack of threshold eﬀ   ect, the authors 
developed a model to predict massive PRBC transfusion 
using receipt of at least 10 PRBC units to deﬁ  ne massive 
transfusion. Potential predictor variables were mathe-
mati  cally transformed to optimise the ﬁ   tting of the 
model. Although this transformation improved the 
mathe  matics of the model, clinicians are left somewhat 
perplexed in interpreting the eﬀ  ect on transfusion risk of 
a unit change in, for example, the reciprocal of the 
natural log of prothrombin time squared! In the model, 
admission systolic blood pressure, base deﬁ  cit,  and 
prothrombin time had strongest association with 
receiving massive transfusion. Th  ese associated para-
meters are not new, but conﬁ  rm what is already known. 
Including the prothrombin time in a model would limit 
the value of the score due to the delay in laboratory 
processing of these samples. When sensitivity in the 
model was set at 90%, a clinically useful cut-oﬀ   point, the 
speciﬁ  city was only 50%, correctly classifying only 58% of 
patients. Th   is means that if this score was used to initiate 
a major haemorrhage protocol and/or haemostatic resus-
ci  tation with PRBCs, fresh frozen plasma, and platelets, 
this would lead to an inappropriate activation on 50% of 
occasions (based on the 10 PRBC unit cut-oﬀ   point). On 
one hand this might be considered an in  appropriate use 
of blood products, but if this method reduced mortality, 
complications or illness cost – espe  cially given the 
relatively linear relationship between PRBC transfusion 
and death shown in the ﬁ   rst model – it might be 
considered clinically eﬀ  ective and cost-eﬀ  ective. High-
quality clinical trials of haemostatic resuscitation therapy 
may help us answer this question.
It would be interesting to compare the performance of 
this predictive model with other published trauma 
scores, such as the Trauma Associated Severe 
Hemor  rhage score [11] or the Assessment of Blood 
Consump  tion score [12], which only used parameters 
available within the ﬁ  rst 15 to 20 minutes of arrival in the 
emer gency department. Th  e Trauma Associated Severe 
Hemor rhage score correctly classiﬁ   ed 89% of cases 
requiring massive transfusion, and the Assessment of 
Blood Con  sump  tion score 85%. Th  ese scores were 
developed in smaller cohorts, however, and whether this 
performance can be replicated in international cohorts 
remains to be seen.
Where does this leave us? Th   e recent CRASH-2 trial of 
tranexamic acid in trauma has shown that simple cheap 
interventions which modify coagulation can improve 
survival in trauma patients [10]. Clarifying the further 
impact of more complex and expensive strategies is 
therefore clearly warranted, because any reduction in 
coagulopathy and/or PRBC transfusion in this setting is 
likely to modify outcome. Despite the large databases and 
complex statistical modelling, Stanworth and colleagues 
have not provided any new predictors for when to 
intervene. We therefore need to continue to search for 
better predictors that could be available within minutes 
of presentation, perhaps based on thromboelastography 
or individual factor levels. Until then, as is usually the 
case in critical care, emphasis should be placed on early 
assessment and continual reassessment by experienced 
clinicians working in an organisation capable of 
delivering therapies quickly and eﬀ  ectively.
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